BioNote (377740) Stock Overview

BioNote, Inc., a biotechnology company, manufactures and sells medical supplies and related other medicaments in South Korea. It offers in-vitro diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company was founded in 2003 and is headquartered in Hwaseong, South Korea.